Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Schlessinger

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Nature|March 25, 2022
Design of protein-binding proteins from the target structure aloneLongxing Cao, Brian Coventry, Inna Goreshnik, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2018
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitorsCharles Li, Elena Bonazzoli, Stefania Bellone, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2026
Integrated mutational landscape analysis of endometrial stromal sarcomaTobias M P Hartwich, Seungji Choi, Ayoung Hwang, et al.
Cell|June 11, 2024
Modulation of FGF pathway signaling and vascular differentiation using designed oligomeric assembliesNatasha I Edman, Ashish Phal, Rachel L Redler, et al.
Nature|September 9, 2010
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanomaGideon Bollag, Peter Hirth, James Tsai, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2021
Integrated mutational landscape analysis of uterine leiomyosarcomasJungmin Choi, Aranzazu Manzano, Weilai Dong, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transitionSiming Zhao, Stefania Bellone, Salvatore Lopez, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2019
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapyLuca Zammataro, Salvatore Lopez, Stefania Bellone, et al.
Nature Communications|March 8, 2016
Data publication with the structural biology data grid supports live analysisPeter A Meyer, Stephanie Socias, Jason Key, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Nature|March 25, 2022
Design of protein-binding proteins from the target structure aloneLongxing Cao, Brian Coventry, Inna Goreshnik, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2018
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitorsCharles Li, Elena Bonazzoli, Stefania Bellone, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2026
Integrated mutational landscape analysis of endometrial stromal sarcomaTobias M P Hartwich, Seungji Choi, Ayoung Hwang, et al.
Cell|June 11, 2024
Modulation of FGF pathway signaling and vascular differentiation using designed oligomeric assembliesNatasha I Edman, Ashish Phal, Rachel L Redler, et al.
Nature|September 9, 2010
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanomaGideon Bollag, Peter Hirth, James Tsai, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2021
Integrated mutational landscape analysis of uterine leiomyosarcomasJungmin Choi, Aranzazu Manzano, Weilai Dong, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transitionSiming Zhao, Stefania Bellone, Salvatore Lopez, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2019
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapyLuca Zammataro, Salvatore Lopez, Stefania Bellone, et al.
Nature Communications|March 8, 2016
Data publication with the structural biology data grid supports live analysisPeter A Meyer, Stephanie Socias, Jason Key, et al.
Pageof 13